PARP inhibitors and epithelial ovarian cancer: Molecular mechanisms, clinical development and future prospective

Loizzi, V; Ranieri, G; Laforgia, M; Gadaleta, CD; Gargano, G; Kardhashi, A; De Liso, M; Naglieri, E; Del Vecchio, V; Cicinelli, E; Cormio, G

Ranieri, G (corresponding author), IRCCS Ist Ricovero & Cura Carattere Sci Giovanni, Intervent & Med Oncol Unit, 65 Viale Orazio Flacco, I-70124 Bari, Italy.

ONCOLOGY LETTERS, 2020; 20 (4):

Abstract

Epithelial ovarian cancer (EOC) has a poor prognosis. Since the introduction of paclitaxel as antineoplastic agent >20 years ago, only a few phase ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索